In absence of a reversible factor therapy, supplementation in most cases is lifelong
Dysesthesia Incidence: Retatrutide 9mg: 8.8% Retatrutide 12mg: 20.9% Placebo: 0.7% Importantly, Eli Lilly reported that: Dysesthesia events were generally mild They infrequently led to discontinuation The mechanism is not yet fully understood This side effect was not observed in Phase 2 trials The appearance of dysesthesia at higher doses suggests it may be dose-dependent
Clinical studies have shown that over 68 weeks, patients on the standard 2.4mg dose can lose around 15-17% of their body weight on average, and up to 1921% on the higher-strength 7.2mg dose [1]
This clinical success has translated into major commercial growth
Evidence from experiments employing somatostatin receptor 2 (SSRT2) antagonists and SSRT2 knockout mice strongly suggests that GLP-1s inhibitory actions on -cells are indirect and partially mediated through somatostatin-dependent mechanisms (132)
6 For these reasons, the timing is primarily based on your goals - if you struggle with energy and pushing through to finish your workout, add it to your pre-workout shake or meal